![Ross Patane](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ross Patane
Directeur Général chez
GROUP ONE CAPITAL LIMITED
Profil
Rosario Patane is Chief Executive Officer, MD & Director at Group One Capital Ltd. since 2025.
Currently holds the position of Director at Henry Morgan Ltd. Holds the title of Associate Member at the Australian Institute of Co. Directors.
Holds the title of Associate at The Institute of Chartered Accountants in Australia.
Former roles include Non-Executive Chairman at Qbiotics Pty Ltd., Non-Executive Director at Australian Securities & Investments Commission, Independent Non-Executive Director at John Bridgeman Ltd. from 2015 to 2020, Non-Executive Director at Henry Morgan Ltd. (Australia) from 2019 to 2020, Director at Benjamin Hornigold Ltd., Trustee at Queensland Art Gallery & Gallery of Modern Art, and Managing Principal at Crowe Horwath from 2012 to 2018.
Postes actifs de Ross Patane
| Sociétés | Poste | Début |
|---|---|---|
| GROUP ONE CAPITAL LIMITED | Directeur Général | 01/11/2025 |
Henry Morgan Ltd.
 Henry Morgan Ltd. Investment Banks/BrokersFinance Provides investment services | Directeur/Membre du Conseil | - |
The Institute of Chartered Accountants in Australia | Corporate Officer/Principal | - |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
Anciens postes connus de Ross Patane
| Sociétés | Poste | Fin |
|---|---|---|
| JOHN BRIDGEMAN LTD | Directeur/Membre du Conseil | 16/01/2020 |
| HENRY MORGAN LTD | Directeur/Membre du Conseil | 16/01/2020 |
Crowe Horwath
 Crowe Horwath Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Corporate Officer/Principal | 02/01/2018 |
| BENJAMIN HORNIGOLD LIMITED | Directeur/Membre du Conseil | - |
Australian Securities & Investments Commission
 Australian Securities & Investments Commission General GovernmentGovernment Operates as an independent commonwealth government body that enforces company and financial services laws to protect consumers, investors and creditors | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
88
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Raptis Group Ltd.
 Raptis Group Ltd. Real Estate DevelopmentFinance Engages in property development | Finance |
Australian Securities & Investments Commission
Australian Securities & Investments Commission General GovernmentGovernment Operates as an independent commonwealth government body that enforces company and financial services laws to protect consumers, investors and creditors | Government |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Queensland Art Gallery & Gallery of Modern Art
 Queensland Art Gallery & Gallery of Modern Art Other Consumer ServicesConsumer Services Provincial art museum | Consumer Services |
The Institute of Chartered Accountants in Australia | |
John Bridgeman Ltd.
 John Bridgeman Ltd. Investment ManagersFinance Provides diversified investment management services | Finance |
Henry Morgan Ltd.
Henry Morgan Ltd. Investment Banks/BrokersFinance Provides investment services | Finance |
Qbiotics Pty Ltd.
 Qbiotics Pty Ltd. Qbiotics Pty Ltd. is an Australian life sciences company specializing in the discovery and development of novel cell signalling small molecules. The company is based in Yungaburra, Australia. The company uses phenotypic screening to discover new solutions for challenging medical conditions, with a clinical focus on treatments for cancer and chronic wounds. Its lead oncology drug, tigilanol tiglate, targets solid tumours and is in phase II human clinical development, while a veterinary formulation is marketed as Stelfonta® in the USA and Australia. Qbiotics also has a wound healing drug candidate, EBC 1013, targeting chronic and acute wounds and burns, currently in phase I clinical development for venous leg ulcers. | |
Crowe Horwath
Crowe Horwath Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Henry Morgan Ltd. (Australia)
 Henry Morgan Ltd. (Australia) Financial ConglomeratesFinance Operates as an investment company | Finance |
Benjamin Hornigold Ltd.
 Benjamin Hornigold Ltd. Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
